Lack of stereospecificity of suid pseudorabies virus thymidine kinase.
暂无分享,去创建一个
G. Maga | L. Bonizzi | G. Poli | A. Garbesi | F. Focher | S. Spadari | A. Verri | W. Ponti | D. Niccolai
[1] G. Maga,et al. L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. , 1992, Journal of medicinal chemistry.
[2] G. Maga,et al. Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases. , 1992, Journal of medicinal chemistry.
[3] H. Akashi,et al. Avirulent ts and thymidine kinase-deficient mutant of Aujeszky's disease virus. , 1991, The Journal of veterinary medical science.
[4] G. Gentry,et al. Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity. , 1990, Acta virologica.
[5] J. D. Karkas,et al. Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro , 1990, Antimicrobial Agents and Chemotherapy.
[6] P. Schaffer,et al. Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia , 1990, Antimicrobial Agents and Chemotherapy.
[7] D. Sandoli,et al. Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases. , 1990, Journal of medicinal chemistry.
[8] D. Sandoli,et al. Nucleoside analogs as non-substrate inhibitors of herpes simplex viruses thymidine kinase. , 1989, Methods and Findings in Experimental and Clinical Pharmacology.
[9] S Spadari,et al. N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase. , 1988, Journal of medicinal chemistry.
[10] Y. Cheng,et al. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus , 1987, Antimicrobial Agents and Chemotherapy.
[11] R. T. Walker,et al. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. , 1986, Journal of medicinal chemistry.
[12] A. Kaplan,et al. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. , 1985, American journal of veterinary research.
[13] S. Kit,et al. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus. , 1985, American journal of veterinary research.
[14] H. Field. Chemotherapy of Aujeszky's disease (pseudorabies) in the mouse by means of nucleoside analogues: bromovinyldeoxyuridine, acyclovir, and dihydroxypropoxymethylguanine. , 1985, Antiviral research.
[15] Y. Cheng,et al. Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function. , 1981, The Journal of biological chemistry.
[16] R. T. Walker,et al. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Schaeffer,et al. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Cornish-Bowden,et al. Statistical considerations in the estimation of enzyme kinetic parameters by the direct linear plot andother methods. , 1974, The Biochemical journal.
[19] W. Prusoff. Synthesis and biological activities of iododeoxyuridine, an analog of thymidine. , 1959, Biochimica et biophysica acta.